BH3 interacting-domain death agonist
| BID | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| human pro-apoptotic protein bid | |||||||||
| Identifiers | |||||||||
| Symbol | BID | ||||||||
| Pfam | PF06393 | ||||||||
| InterPro | IPR010479 | ||||||||
| SCOP2 | 1ddb / SCOPe / SUPFAM | ||||||||
| TCDB | 1.A.21 | ||||||||
| OPM superfamily | 40 | ||||||||
| OPM protein | 2m5i | ||||||||
| 
 | |||||||||
The BH3 interacting-domain death agonist, or BID, gene is a pro-apoptotic member of the Bcl-2 protein family. Bcl-2 family members share one or more of the four characteristic domains of homology entitled the Bcl-2 homology (BH) domains (named BH1, BH2, BH3 and BH4), and can form hetero- or homodimers. Bcl-2 proteins act as anti- or pro-apoptotic regulators that are involved in a wide variety of cellular activities.